No Data
Does Guizhou Xinbang Pharmaceutical (SZSE:002390) Have A Healthy Balance Sheet?
Guizhou Xinbang Pharmaceutical (002390.SZ): Its hospital offers testing services such as lymphocyte subgroups, lymphocyte activation, dendritic cells, cell apoptosis, and leukemia immune analysis.
Guizhou Xinbang Pharmaceutical (002390.SZ) stated on the investor interaction platform that its hospitals have testing services for lymphocyte subsets, lymphocyte activation, dendritic cells, cell apoptosis, and leukemia immunological analysis.
Guizhou Xinbang Pharmaceutical (002390.SZ): The produced Yixin Shu Capsule, Maixue Kang Capsule, silver ginkgo biloba leaves, and Dengzhanhua Drip are suitable for the middle-aged and elderly population.
On September 19, Guizhou Xinbang Pharmaceutical (002390.SZ) stated on the investor interaction platform that the company's produced Yixinshu capsules, Maixuekang capsules, ginkgo biloba leaves, and dandelion drops are suitable for the middle-aged and elderly population. As the leading pharmaceutical circulation company in Guizhou Province, the company has formed a comprehensive distribution system that includes both pharmaceuticals and medical devices. The pharmaceuticals sold by the company's subsidiary pharmaceutical distribution company include the category you are interested in. Currently, Guizhou Medical University affiliated Baiyun Hospital, under the company, has set up sanatoriums in the department of general practice medicine, providing professional treatment and care for elderly patients.
Xinbang Pharmaceuticals: 2024 Semi-Annual Report Summary
Xinbang Pharmaceuticals: 2024 Semi-Annual Report
Guizhou Xinbang Pharmaceutical (002390.SZ) released its semi-annual performance, with a net income of 0.115 billion yuan, a decrease of 26.37%.
Guizhou Xinbang Pharmaceutical (002390.SZ) released its 2024 interim report. During the reporting period, the company achieved revenue...
Earnings Growth of 1.1% Over 3 Years Hasn't Been Enough to Translate Into Positive Returns for Guizhou Xinbang Pharmaceutical (SZSE:002390) ShareholdersNo Data
No Data
